<- Go Home
Embrex LLC
Embrex LLC operates as a biotechnology company that develops in-ovo vaccination devices for the poultry industry in USA and internationally. Its product line includes Inovoject system, a biodevice for the protection of chicks from disease challenges; Inovoject M, a biodevice designed to meet the needs of smaller hatcheries that do not process enough eggs; and Inovoject Vaccine Saver system that enhances the productivity of the in-ovo vaccination process. The company also offers an egg remover system that identifies and removes infertile and early dead eggs; and a chick counter, a biodevice system for chick counting through automation. Additionally, the company also offers vaccine manufacturers and research institutes, with a range of devices, including VMD ERH and EMBREX VMD ERV device that uses an infra-red system in conjunction with a heartbeat detector to identify infertile eggs and/or embryos that are no longer alive; VMD VAI biodevice that is used by pharmaceutical companies to manufacture a range of human and animal vaccines, including human influenza vaccine; and VMD VMI biodevice for egg-based vaccine production. The company was founded in 1992 and is based in Parsippany, New Jersey. Embrex LLC operates as a subsidiary of Zoetis Inc.
Market Cap
$142.7M
Volume
25.5K
Cash and Equivalents
$3.0M
EBITDA
$11.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$31.6M
Profit Margin
58.11%
52 Week High
$17.00
52 Week Low
$8.70
Dividend
N/A
Price / Book Value
2.47
Price / Earnings
54.68
Price / Tangible Book Value
2.80
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$3.8M
Return on Equity
4.79%
Return on Assets
3.37
Cash and Short Term Investments
$3.0M
Debt
$9.9M
Equity
$57.4M
Revenue
$54.4M
Unlevered FCF
-$2.3M
Sector
Biotechnology
Category
N/A